Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Medifocus Inc MDFZF

Healthcare Biotechnology
Medifocus Inc develops and sells minimally invasive focused heat systems for the treatment of cancerous and benign tumors, and enlarged prostate, medically known as Benign Prostate Hyperplasia (BHP). It owns two focused heat technology platforms, The Endo-thermotherapy Platform-from which Prolieve was developed, can be used to treat cancers in prostate, rectal, cervical and esophageal, and The... see more

Recent & Breaking News (EXPM:MDFZF)

Medifocus, Inc. Announces SEC Deregistration

Accesswire May 12, 2022

Medifocus Inc. Announces Plans to Undergo Balance Sheet Restructuring

Accesswire September 17, 2021

IIROC Trading Halt - MFS

Canada NewsWire September 8, 2020

Medifocus Inc. Announces Resignation of Chief Financial Officer

GlobeNewswire August 21, 2020

Medifocus Inc. Announces Delayed Filing of Annual Disclosure Documents Pursuant to OSC Instrument 51-502

GlobeNewswire July 24, 2020

Medifocus, Inc. Announces Increase in Revenue and Positive Cash Flow from Operation in Fiscal Year Ended March 31, 2019 and Global Market Expansion with Prolieve(R) Procedures Performed in Singapore

Newsfile August 29, 2019

Medifocus, Inc. Announces Global Market Expansion with Prolieve® Performed and Reimbursed by Insurance Carriers in Hong Kong

GlobeNewswire January 3, 2019

Medifocus, Inc. Announces Recent Publication Highlighting Its Focal Therapy for Prostate and Breast Cancer Treatment Initiatives

GlobeNewswire December 27, 2018

Uptick Newswire’s Stock Day Podcast Hosts Medifocus, Inc.’s CEO to Discuss Their Minimally Invasive Breakthrough Treatments for Prostate and Breast Cancers

GlobeNewswire December 10, 2018

Medifocus, Inc. Announces FDA PMA Supplement Approval for New Labeling Based on Successful Completion of FDA Post Approval Study (PAS) for the Prolieve® Thermodilatation™ Device

GlobeNewswire December 3, 2018

Medifocus, Inc. Submits For New Patent Titled “Thermodilatation and Thermocompression to Facilitate Targeted Cluster Tissue Ablation and Immune Response”

Accesswire November 29, 2018

Medifocus, Inc. Announces 26% Increase in Revenue in Recent Quarter and Positive Cash Flow from Operation for the Six Months Ended Sept 30, 2018

Accesswire November 27, 2018

Medifocus Inc.’s General Manager and Medical Director Discuss Their Breakthrough Products with Uptick Newswire’s Stock Day Podcast

GlobeNewswire October 31, 2018

Medifocus, Inc. Announces Successful Completion of FDA Post Approval Study (PAS) for the Prolieve (R) Thermodilatation(TM) System

Accesswire June 5, 2018

Medifocus, Inc. Expands Its Reach into the Israeli Market with Amos Gazit Ltd. for Its Prolieve(R) Thermodilatation for BPH Therapy and Announces Significant Debt Conversion into Shares

Accesswire January 9, 2018

Medifocus, Inc. Announces Significant Improvement in Operating Results for the Fiscal Year Ending March 31, 2017

Accesswire August 28, 2017

Medifocus, Inc. Announces First Ever Quarterly Operating Profit and Significant Improvement in Operating Results for the Nine Months Ended December 31, 2016

Accesswire March 16, 2017

Medifocus, Inc. Announces Significant Improvement in Operating Results for the Six Months Ended September 30, 2016

Accesswire December 19, 2016

Medifocus Inc. Announces Appointment of New Chief Executive Officer

Canada NewsWire October 3, 2016

Medifocus Inc. Announces Election of Directors and Financial Results for the Quarter Ended June 30 2016

Canada NewsWire September 14, 2016